779 related articles for article (PubMed ID: 22270643)
1. Quantifying the chemical beauty of drugs.
Bickerton GR; Paolini GV; Besnard J; Muresan S; Hopkins AL
Nat Chem; 2012 Jan; 4(2):90-8. PubMed ID: 22270643
[TBL] [Abstract][Full Text] [Related]
2. Quantitative Estimate Index for Early-Stage Screening of Compounds Targeting Protein-Protein Interactions.
Kosugi T; Ohue M
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681589
[TBL] [Abstract][Full Text] [Related]
3. Drug-likeness and increased hydrophobicity of commercially available compound libraries for drug screening.
Zuegg J; Cooper MA
Curr Top Med Chem; 2012; 12(14):1500-13. PubMed ID: 22827520
[TBL] [Abstract][Full Text] [Related]
4. Not Drug-like, but Like Drugs: Cnidaria Natural Products.
Laguionie-Marchais C; Allcock AL; Baker BJ; Conneely EA; Dietrick SG; Kearns F; McKeever K; Young RM; Sierra CA; Soldatou S; Woodcock HL; Johnson MP
Mar Drugs; 2021 Dec; 20(1):. PubMed ID: 35049897
[TBL] [Abstract][Full Text] [Related]
5. The application of in silico drug-likeness predictions in pharmaceutical research.
Tian S; Wang J; Li Y; Li D; Xu L; Hou T
Adv Drug Deliv Rev; 2015 Jun; 86():2-10. PubMed ID: 25666163
[TBL] [Abstract][Full Text] [Related]
6. Considering the impact drug-like properties have on the chance of success.
Yusof I; Segall MD
Drug Discov Today; 2013 Jul; 18(13-14):659-66. PubMed ID: 23458995
[TBL] [Abstract][Full Text] [Related]
7. How drug-like are 'ugly' drugs: do drug-likeness metrics predict ADME behaviour in humans?
Ritchie TJ; Macdonald SJ
Drug Discov Today; 2014 Apr; 19(4):489-95. PubMed ID: 24462956
[TBL] [Abstract][Full Text] [Related]
8. Scopy: an integrated negative design python library for desirable HTS/VS database design.
Yang ZY; Yang ZJ; Lu AP; Hou TJ; Cao DS
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32892221
[TBL] [Abstract][Full Text] [Related]
9. Development of a method for evaluating drug-likeness and ease of synthesis using a data set in which compounds are assigned scores based on chemists' intuition.
Takaoka Y; Endo Y; Yamanobe S; Kakinuma H; Okubo T; Shimazaki Y; Ota T; Sumiya S; Yoshikawa K
J Chem Inf Comput Sci; 2003; 43(4):1269-75. PubMed ID: 12870920
[TBL] [Abstract][Full Text] [Related]
10. Present drug-likeness filters in medicinal chemistry during the hit and lead optimization process: how far can they be simplified?
Mignani S; Rodrigues J; Tomas H; Jalal R; Singh PP; Majoral JP; Vishwakarma RA
Drug Discov Today; 2018 Mar; 23(3):605-615. PubMed ID: 29330127
[TBL] [Abstract][Full Text] [Related]
11. ADMET-score - a comprehensive scoring function for evaluation of chemical drug-likeness.
Guan L; Yang H; Cai Y; Sun L; Di P; Li W; Liu G; Tang Y
Medchemcomm; 2019 Jan; 10(1):148-157. PubMed ID: 30774861
[TBL] [Abstract][Full Text] [Related]
12. Drug and drug candidate building block analysis.
Wang J; Hou T
J Chem Inf Model; 2010 Jan; 50(1):55-67. PubMed ID: 20020714
[TBL] [Abstract][Full Text] [Related]
13. Working with small molecules: rules-of-thumb of "drug likeness".
Zhang MQ
Methods Mol Biol; 2012; 803():297-307. PubMed ID: 22065233
[TBL] [Abstract][Full Text] [Related]
14. The influence of drug-like concepts on decision-making in medicinal chemistry.
Leeson PD; Springthorpe B
Nat Rev Drug Discov; 2007 Nov; 6(11):881-90. PubMed ID: 17971784
[TBL] [Abstract][Full Text] [Related]
15. A practical view of 'druggability'.
Keller TH; Pichota A; Yin Z
Curr Opin Chem Biol; 2006 Aug; 10(4):357-61. PubMed ID: 16814592
[TBL] [Abstract][Full Text] [Related]
16. Selection criteria for drug-like compounds.
Muegge I
Med Res Rev; 2003 May; 23(3):302-21. PubMed ID: 12647312
[TBL] [Abstract][Full Text] [Related]
17. Drug-likeness analysis of traditional Chinese medicines: prediction of drug-likeness using machine learning approaches.
Tian S; Wang J; Li Y; Xu X; Hou T
Mol Pharm; 2012 Oct; 9(10):2875-86. PubMed ID: 22738405
[TBL] [Abstract][Full Text] [Related]
18. Model-free drug-likeness from fragments.
Ursu O; Oprea TI
J Chem Inf Model; 2010 Aug; 50(8):1387-94. PubMed ID: 20726597
[TBL] [Abstract][Full Text] [Related]
19. The impact of physicochemical and molecular properties in drug design: navigation in the "drug-like" chemical space.
Vallianatou T; Giaginis C; Tsantili-Kakoulidou A
Adv Exp Med Biol; 2015; 822():187-94. PubMed ID: 25416989
[TBL] [Abstract][Full Text] [Related]
20. Descriptors, physical properties, and drug-likeness.
Brüstle M; Beck B; Schindler T; King W; Mitchell T; Clark T
J Med Chem; 2002 Aug; 45(16):3345-55. PubMed ID: 12139446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
